|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?|
|Soon Kyu Lee, Jung Hyun Kwon|
|Clin Mol Hepatol. 2023;29(3):825-827. Published online 2023 May 31 DOI: https://doi.org/10.3350/cmh.2023.0185|
HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
Peripheral and intrahepatic virological phenotyping in HBeAg negative Chronic Hepatitis B to evaluate risk of disease progression and HCC in the “grey-zone” viral load cohort: Can grey-zone patients be candidate to treatment?
Reperfusion Is Delayed Beyond Guideline Recommendations in Patients Requiring Interhospital Helicopter Transfer for Treatment of STEMI
Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients
HBeAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Nucleos(t)ide Analog Treatment: A Systematic Review and Network Meta-Analysis
Liver Inflammation and Fibrosis of HBeAg-Negative Patients in the Grey Zone
Association of Dyslipidemia With Nucleoside Analogue Treatment in HBeAg-Positive Chronic Hepatitis B Patients
1031 DURABILITY OF PEGINTERFERON ALFA-2B TREATMENT BEYOND 5 YEARS IN PATIENTS WITH HEPATITIS B E ANTIGEN (HBEAG) POSITIVE CHRONIC HEPATITIS B
On-treatment HBV DNA level could predict HBeAg seroclearance in patients with HBeAg-positive chronic hepatitis B with entecavir therapy
Treatment of heterosexual and homosexual patients with HBeAG positive chronic hepatitis B with low dose interferon alpha (IFN-A)
|This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.|